AI assistant
Sending…
RESMED INC — Director's Dealing 2012
May 4, 2012
30071_dirs_2012-05-04_49099c4b-279b-4749-aa72-9aee8ffeaaed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-05-02
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-02 | ResMed Common Stock | M | 20000 | $23.095 | Acquired | 148410.086 | Direct |
| 2012-05-02 | ResMed Common Stock | S | 20000 | $35.00 | Disposed | 128866.301 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-02 | ResMed Common Stock Options | $23.095 | M | 20000 | Disposed | 2013-11-10 | ResMed Common Stock (20000) | Direct |
Footnotes
F1: Trade was executed pursuant to a 10b5-1 trading plan.
F2: Represents date options first became exercisable. Options vest 1/4 annually until fully vested.
F3: Includes 456.216 shares purchased on April 30, 2012 pursuant to company's Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29